BioStock News
@BioStock_News
Followers
229
Following
26
Media
24
Statuses
772
BioStock is a digital news and analysis service focused on the Scandinavian Life Science sector based in Sweden. (For news in Swedish, check out @BioStock_SWE)
Lund, Sverige
Joined January 2020
Aptahem reports promising outcome from the additional analyses on the mechanism on lead candidate Apta-1 in the FIH study https://t.co/9H4JykVqrN
#BioStockSwe #lifescience #Aptahem
news.cision.com
Aptahem AB (publ) announces today that the results from the additional analyses performed in
0
0
0
Stayble reports last patient last visit in the phase IIb study #BioStockSwe #LifeScience @Stayble
https://t.co/CC08ihQgGv
0
0
1
Chordate Medical launches the trademark Ozilia #BioStock_News #LifeScience @ChordateMedical
https://t.co/tr3QEtF22q
0
0
1
Revolutionizing Vaccine Discovery: New Data Validates @EvaxionBiotech AI Platform, Offering Promise to Reduce Risk and Cost in Infectious Disease Vaccine Development. #BioStock_Swe #lifescience
https://t.co/NhBHkxyEBF
globenewswire.com
Evaxion is the first organization to validate an AI model that outcompetes state-of-the-art vaccine developmentEvaxion's AI model predicts vaccine efficacy...
0
0
0
SynAct Pharma’s CEO comments on EXPAND data #BioStockSwe #LifeScience #SynActPharma
https://t.co/Wuck1WaHDL
0
0
0
Stayble Therapeutics enrols the first patient in herniated disc study #BioStockSwe #LifeScience @Stayble
https://t.co/idecwxoM5Y
biostock.se
Stayble Therapeutic enrolls the first patient in the phase Ib study with STA363 on disc herniation. CEO Gerward comments on the milestone
0
0
0
Lipum reports Q2 and increases the pace #BioStockSwe #LifeScience
@lipumpharma
https://t.co/SItvbvjfyc
0
0
0
BiBB coming off strong first half of 2023 https://t.co/ZMwYy0FOmA
#lifescience #BioStockSwe @bibbinstruments
0
0
0
Alligator Bioscience expands orphan designation to Europe https://t.co/p83FJhXxK1
#lifescience #BioStockSwe @AlligatorBio
0
0
0
Lipum publishes important results in journal #BioStockNews #LifeScience @lipumpharma
https://t.co/jXtPrAdN6v
biostock.se
Interview with Lipum's CSO Susanne Lindquist regarding BSSL, the publication in PLOS ONE and the possibilities with drug candidate SOL-116
0
0
0
Progress for Stayble Therapeutics in the second quarter #BioStockNews #LifeScience @Stayble
https://t.co/BVQs4YrA0T
biostock.se
Second quarter was a busy period for Stayble Therapeutics with several important achievements, for example a successful capital raise
0
0
0
Enzymatica’s CEO comments on promising in-vitro data for ColdZyme #BioStockSwe #LifeScience @Enzymatica_AB
https://t.co/TEKRhzAcMz
biostock.se
Interview with Enzymatica's CEO Claus Egstrand on the study at Medical University of Innsbruck showing that ColdZyme breaks the infection cycle
0
0
0
Evaxion reaches key milestones during summer https://t.co/AzObvz5bOR
#BioStockSwe #lifescience @EvaxionBiotech
0
0
0
International specialist congress and upcoming milestones for @ChordateMedical
#BioStockSwe #LifeScience
https://t.co/HWnS9Qs29A
0
0
0
Dicot gets green light for start of phase I study #BioStock_News #LifeScience
https://t.co/tgTxT8Cl4M
0
0
0
Arcede hopes to reach larger market than existing drugs #BioStock_News #LifeScience
https://t.co/0y94dLBxlU
0
0
0
Aqilion has completed Phase 1 study with AQ280 within the Regulus program #BioStock_News #lifescience #Aqilion
https://t.co/wbuud7Mo0r
news.cision.com
AQILION (publ) announces today that it has successfully completed the first clinical study in
0
0
0
Respiratorius’ CEO comments on the second quarter #BioStock_News #lifescience
https://t.co/vcBkwin610
0
0
0
Aptahem comments on the paused phase I study https://t.co/doWArZ3l5x
#lifescience #BioStockSwe #Aptahem
0
0
0